Travere Therapeutics, Inc. (TVTX)
52.79
-0.48
(-0.90%)
USD |
NASDAQ |
Oct 15, 16:00
52.75
-0.04
(-0.08%)
After-Hours: 20:00
Travere Therapeutics Cash from Operations (TTM) : 92.70M for June 30, 2026
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 92.70M |
| March 31, 2026 | 39.61M |
| December 31, 2025 | 37.78M |
| September 30, 2025 | -58.61M |
| June 30, 2025 | -115.44M |
| March 31, 2025 | -160.66M |
| December 31, 2024 | -237.48M |
| September 30, 2024 | -272.23M |
| June 30, 2024 | -288.86M |
| March 31, 2024 | -317.91M |
| December 31, 2023 | -280.02M |
| September 30, 2023 | -264.19M |
| June 30, 2023 | -244.58M |
| March 31, 2023 | -212.09M |
| December 31, 2022 | -186.29M |
| September 30, 2022 | -158.53M |
| June 30, 2022 | -86.94M |
| March 31, 2022 | -43.64M |
| December 31, 2021 | -14.79M |
| September 30, 2021 | -1.785M |
| June 30, 2021 | -27.11M |
| March 31, 2021 | -40.06M |
| December 31, 2020 | -42.74M |
| September 30, 2020 | -33.36M |
| June 30, 2020 | -54.22M |
| Date | Value |
|---|---|
| March 31, 2020 | -66.88M |
| December 31, 2019 | -58.21M |
| September 30, 2019 | -57.29M |
| June 30, 2019 | -47.06M |
| March 31, 2019 | -30.72M |
| December 31, 2018 | -24.96M |
| September 30, 2018 | -22.25M |
| June 30, 2018 | -12.15M |
| March 31, 2018 | -4.555M |
| December 31, 2017 | 7.403M |
| September 30, 2017 | 1.494M |
| June 30, 2017 | 0.04M |
| March 31, 2017 | -0.805M |
| December 31, 2016 | -1.596M |
| September 30, 2016 | 2.618M |
| June 30, 2016 | -0.697M |
| March 31, 2016 | 3.212M |
| December 31, 2015 | -0.554M |
| September 30, 2015 | -7.099M |
| June 30, 2015 | -24.03M |
| March 31, 2015 | -43.38M |
| December 31, 2014 | -45.85M |
| September 30, 2014 | -44.90M |
| June 30, 2014 | -32.06M |
| March 31, 2014 | -22.82M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| TG Therapeutics, Inc. | 17.88M |
| BioMarin Pharmaceutical, Inc. | 857.09M |
| Vertex Pharmaceuticals, Inc. | 4.293B |
| Viridian Therapeutics, Inc. | -333.82M |
| Krystal Biotech, Inc. | 272.34M |